跳至主要内容
临床试验/EUCTR2018-002856-34-NL
EUCTR2018-002856-34-NL进行中(未招募)1 期

Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus® and Advagraf® in de novo liver transplant recipients. - MOTTO

Foundation for Liver research0 个研究点目标入组 106 人开始时间: 2018年10月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • First liver transplantation
  • Age between 18 and 75
  • Using immediate release tacrolimus
  • Female subjects of childbearing potential must agree to practice effective birth control during the study
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 26

排除标准

  • Pregnancy
  • eGFR < 30 mL/min/1.73m2
  • Systemic infection
  • Combined organ transplantation
  • Use of a mTOR inhibitor
  • Use of other tacrolimus formulations
  • Hepatic artery trombosis
  • Known allergy to the study drug or any of its components

研究者

发起方
Foundation for Liver research

相似试验